Skip to Main Content

Paper Details

Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
J Clin Invest
4
2017
ABL, BCR, PI3K, human, human BCR-ABL+ leukemia cells, mTOR, mice

Datasets